Question

A 64-year-old with newly diagnosed HFrEF (EF 30%) is euvolemic. Which regimen reflects current guideline-directed initial disease-modifying therapy?

Accepted Answer

ARNI, evidence-based beta-blocker, MRA, and SGLT2 inhibitor

Answer

ACE inhibitor alone

Answer

Beta-blocker and loop diuretic only

Answer

Ivabradine and hydralazine-isosorbide dinitrate only

Answer

Digoxin plus loop diuretic

Practice question

A 64-year-old with newly diagnosed HFrEF (EF 30%) is euvolemic. Which regimen reflects current guideline-directed initial disease-modifying therapy?